Hyperhomocysteinemia in men population of Novosibirsk
Abstract
In population to the Siberian sample of men the prevalence of hyperhomocysteinemia (HHC) in winter-spring and in autumn seasons of year for the first time is studied, search of theoretically expected associations with CHD and with major factors of its risk is lead. It is executed a screening examination of representative sample of 243 men of 45-69 years with use of the standardized epidemiological and biochemical methods. The prevalence of HHC during the winter-spring period of year has made 43 %, during an autumn season of year has made 52 %. Statistically significant distinctions in the prevalence of HHC between seasons of year it is not revealed. It is not revealed correlation communications between a level of homocysteine blood and presence CHD. Positive correlation of homocysteinemia with the years, with a level of products of lipid peroxidation in IDI, and also its negative correlation with α-tocopherol level in LDL and with an index of weight of a body.
About the Authors
Yu. P. Nikitin
Научно-исследовательский институт терапии СО РАМН
Russian Federation
Russian Federation
O. V. Motina
Научно-исследовательский институт терапии СО РАМН
Russian Federation
Russian Federation
Yu. I. Ragino
Научно-исследовательский институт терапии СО РАМН
Russian Federation
Russian Federation
G. I. Simonova
Научно-исследовательский институт терапии СО РАМН
Russian Federation
Russian Federation
Ya. V. Polonskaya
Научно-исследовательский институт терапии СО РАМН
Russian Federation
Russian Federation
M. V. Ivanova
Научно-исследовательский институт терапии СО РАМН
Russian Federation
Russian Federation
L. V. Cherbakova
Научно-исследовательский институт терапии СО РАМН
Russian Federation
Russian Federation
S. K. Malyutina
Научно-исследовательский институт терапии СО РАМН
Russian Federation
Russian Federation
References
1. Баранова Е.И., Большакова О.О. Клиническое значение гомоцистеинемии//Артериальная гипертензия. 2004. Т. 10, № 1. С. 12-15.
2. Оганов Р.Г., Масленникова Г.Я. Проблемы профилактики сердечно-сосудистых заболеваний в России//Кардиология СНГ 2003; 1: 12-15.
3. Рагино Ю.И., Воевода М.И., Душкин М.И. и др. Применение новых биохимических способов для оценки окислительно-антиоксидантного потенциала липопротеинов низкой плотности//Клиническая лабораторная диагностика 2005; 1: 5-9.
4. Симонова Г.И., Никитин Ю.П. Эпидемиология питания и сердечно-сосудистые заболевания в Сибири//Тез. докл. Рос. нац. конгресса кардиологов. М., 2001. С. 344.
5. Шевченко О.П., Олефриенко Г.А. Гипергомоцистеинемия и ее клиническое значение//Лаборатория 2002; 1: 3-7.
6. Booth G., Wang E. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events//CMA J., 2000; 163 (1): 21-9.
7. Mayer E., Jacobsen D., Robinson К. Homocysteine and coronary atherosclerosis//J. Am. Coll. Cardiol. 1996; 27: 517-527.
8. Refsum H., Smith A.D., Ueland P.M. et al. (12 authors). Facts and recommendations about total homocysteine determinations: an expert opinion//Clinical Chemistry 2004; 1: 1-32.
9. Stander O., Herrmann W., Pietrzik K. et al. DACH-LIGA Homocystein (German, Austrian and Swiss Homocysteine Society): Consensus Paper on the Rational Clinical Use of Homocysteine, Folic Acid and B-Vitamins in cardiovascular and Thrombotic Diseases: Guidelines and Recommendations.//Clin. Chem. Lab. Med. 2003; 41(10): 1392-1403.
10. Stacker R., Keaney J.F. Role of oxidative modifications in atherosclerosis//Physiol. Rev 2004; 84: 1381-1478.
11. Warren C. Emergent cardiovascular risk factor: Homocysteine//Prog. Cardiovasc. Nurs. 2002; 17: 35-41.
12. Welch G., Loscalo J. Homocysteine and atherothrombosis//New Engl. J. Med. 1998; 338 (15): 1042-1050.
Review
For citations:
Nikitin Yu.P., Motina O.V., Ragino Yu.I., Simonova G.I., Polonskaya Ya.V., Ivanova M.V., Cherbakova L.V., Malyutina S.K. Hyperhomocysteinemia in men population of Novosibirsk. Russian Journal of Cardiology. 2007;(4):63-68. (In Russ.)
Views:
467
Email this article 